{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T16:02:49Z","timestamp":1772726569882,"version":"3.50.1"},"reference-count":19,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,2,1]]},"abstract":"<jats:p>Mevalonic aciduria (MA) represents the severest form of mevalonate kinase deficiency due to recessively inherited, loss-of-function MVK mutations. MA is an early-onset disorder characterized by a marked failure to thrive, diverse neurologic symptoms, dysmorphic features, and recurrent febrile episodes. However, significant clinical differences have been reported in the few cases published to date. Here we describe 2 unrelated Spanish patients with MA, emphasizing the clinical heterogeneity observed. One patient presented with the severe classic MA phenotype due to the homozygous p.Ile-268-Thr MVK genotype, with a poor response to conventional treatments. However, the anti-interleukin 1 agent anakinra in this patient resulted in improvement in many clinical and laboratory parameters. The second patient presented with an atypical milder phenotype because of an older age at disease onset, mild neurologic symptoms, absence of febrile episodes and dysmorphic features, and moderate-to-good response to conventional treatments. The novel p.Arg-241-Cys MVK mutation, associated with the already known p.Ser-135-Leu mutation, detected in this patient expands the genetic diversity of mevalonate kinase deficiency. This atypical presentation of MA suggests that it should be included in the differential diagnosis of unclassified patients with psychomotor retardation, failure to thrive or ataxia, even in the absence of febrile episodes.<\/jats:p>","DOI":"10.1542\/peds.2010-2192","type":"journal-article","created":{"date-parts":[[2012,1,24]],"date-time":"2012-01-24T05:34:55Z","timestamp":1327383295000},"page":"e535-e539","source":"Crossref","is-referenced-by-count":30,"title":["Clinical, Genetic, and Therapeutic Diversity in 2 Patients With Severe Mevalonate Kinase Deficiency"],"prefix":"10.1542","volume":"129","author":[{"given":"Angeles","family":"Ruiz Gomez","sequence":"first","affiliation":[{"name":"Metabolic Diseases Unit, Pediatric Neurology Department, Hospital Universitario Son Dureta, Palma de Mallorca, Spain;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Luz","family":"Couce","sequence":"additional","affiliation":[{"name":"Metabolic Diseases Unit, Pediatrics Department, Hospital Cl\u00ednico Universitario, Santiago de Compostela, Spain;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judit","family":"Garcia-Villoria","sequence":"additional","affiliation":[{"name":"Inherited Metabolic Disorders Department, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angeles","family":"Torres","sequence":"additional","affiliation":[{"name":"Metabolic Diseases Unit, Pediatric Neurology Department, Hospital Universitario Son Dureta, Palma de Mallorca, Spain;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Ba\u00f1a Souto","sequence":"additional","affiliation":[{"name":"Metabolic Diseases Unit, Pediatrics Department, Hospital Cl\u00ednico Universitario, Santiago de Compostela, Spain;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Yag\u00fce","sequence":"additional","affiliation":[{"name":"Immunology Department, Centro de Diagn\u00f3stico Biom\u00e9dico\/Institut D'Investigacions Biom\u00e8diques August Pi i Sunye, Hospital Cl\u00ednic, Barcelona, Spain; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Antonia","family":"Vilaseca","sequence":"additional","affiliation":[{"name":"Metabolic Diseases Unit, Hospital Sant Joan de D\u00e9u, Esplugues, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia","family":"Ribes","sequence":"additional","affiliation":[{"name":"Inherited Metabolic Disorders Department, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan I.","family":"Ar\u00f3stegui","sequence":"additional","affiliation":[{"name":"Immunology Department, Centro de Diagn\u00f3stico Biom\u00e9dico\/Institut D'Investigacions Biom\u00e8diques August Pi i Sunye, Hospital Cl\u00ednic, Barcelona, Spain; and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2012,2,1]]},"reference":[{"issue":"3","key":"2021120903090989700_B1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1055\/s-2001-16618","article-title":"Inherited disorders of cholesterol biosynthesis","volume":"32","author":"Haas","year":"2001","journal-title":"Neuropediatrics"},{"issue":"25","key":"2021120903090989700_B2","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1056\/NEJM198606193142504","article-title":"Mevalonic aciduria\u2014an inborn error of cholesterol and nonsterol isoprene biosynthesis","volume":"314","author":"Hoffmann","year":"1986","journal-title":"N Engl J Med"},{"issue":"2","key":"2021120903090989700_B3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/9691","article-title":"Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome","volume":"22","author":"Houten","year":"1999","journal-title":"Nat Genet"},{"issue":"2","key":"2021120903090989700_B4","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/9696","article-title":"Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome","volume":"22","author":"Drenth","year":"1999","journal-title":"Nat Genet"},{"issue":"6","key":"2021120903090989700_B5","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/MD.0b013e318190cfb7","article-title":"Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome","volume":"87","author":"van der Hilst","year":"2008","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"2021120903090989700_B6","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1212\/01.WNL.0000115390.33405.F7","article-title":"Mevalonate kinase deficiency: Evidence for a phenotypic continuum","volume":"62","author":"Simon","year":"2004","journal-title":"Neurology"},{"key":"2021120903090989700_B7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1750-1172-1-13","article-title":"Mevalonate kinase deficiencies: from mevalonic aciduria to hyperimmunoglobulinemia D syndrome","volume":"1","author":"Haas","year":"2006","journal-title":"Orphanet J Rare Dis"},{"key":"2021120903090989700_B8"},{"issue":"25","key":"2021120903090989700_B9","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1056\/NEJM200306193482523","article-title":"Interleukin-1-receptor antagonist in the Muckle-Wells syndrome","volume":"348","author":"Hawkins","year":"2003","journal-title":"N Engl J Med"},{"issue":"6","key":"2021120903090989700_B10","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJMoa055137","article-title":"Neonatal-onset multisystem inflammatory disease responsive to interleukin-1\u03b2 inhibition","volume":"355","author":"Goldbach-Mansky","year":"2006","journal-title":"N Engl J Med"},{"issue":"4","key":"2021120903090989700_B11","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/sj.ejhg.5200614","article-title":"Molecular analysis of MVK mutations and enzymatic activity in hyper-IgD and periodic fever syndrome","volume":"9","author":"Cuisset","year":"2001","journal-title":"Eur J Hum Genet"},{"issue":"8","key":"2021120903090989700_B12","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1093\/hmg\/8.8.1523","article-title":"Identification and characterization of three novel missense mutations in mevalonate kinase cDNA causing mevalonic aciduria, a disorder of isoprene biosynthesis","volume":"8","author":"Houten","year":"1999","journal-title":"Hum Mol Genet"},{"issue":"10","key":"2021120903090989700_B13","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1002\/art.10550","article-title":"Lack of isoprenoid products raises ex vivo interleukin-1\u03b2 secretion in hyperimmunoglobulinemia D and periodic fever syndrome","volume":"46","author":"Frenkel","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"8","key":"2021120903090989700_B14","doi-asserted-by":"crossref","first-page":"4936","DOI":"10.4049\/jimmunol.173.8.4936","article-title":"Geranylgeraniol regulates negatively caspase-1 autoprocessing: implication in the Th1 response against Mycobacterium tuberculosis","volume":"173","author":"Montero","year":"2004","journal-title":"J Immunol"},{"issue":"2","key":"2021120903090989700_B15","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","article-title":"The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-\u03b2","volume":"10","author":"Martinon","year":"2002","journal-title":"Mol Cell"},{"issue":"7","key":"2021120903090989700_B16","first-page":"260","article-title":"Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome: introducing a vaccination provocation model","volume":"63","author":"Bodar","year":"2005","journal-title":"Neth J Med"},{"issue":"6","key":"2021120903090989700_B17","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s10545-006-0408-7","article-title":"Anakinra is safe and effective in controlling hyperimmunoglobulinaemia D syndrome-associated febrile crisis","volume":"29","author":"Cailliez","year":"2006","journal-title":"J Inherit Metab Dis"},{"issue":"26","key":"2021120903090989700_B18","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1056\/NEJMoa070715","article-title":"Allogeneic bone marrow transplantation in mevalonic aciduria","volume":"356","author":"Neven","year":"2007","journal-title":"N Engl J Med"},{"issue":"13","key":"2021120903090989700_B19","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJMc072018","article-title":"Mevalonic aciduria cured by bone marrow transplantation","volume":"357","author":"Arkwright","year":"2007","journal-title":"N Engl J Med"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/129\/2\/e535\/1056367\/peds_2010-2192.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/129\/2\/e535\/1056367\/peds_2010-2192.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T17:07:09Z","timestamp":1639069629000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/129\/2\/e535\/32498\/Clinical-Genetic-and-Therapeutic-Diversity-in-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,1]]},"references-count":19,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2012,2,1]]},"published-print":{"date-parts":[[2012,2,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2010-2192","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,1]]}}}